Boston, MA · Founded 2019 · Privately Held (backing)
Developer of transdermal drug delivery technology designed to reformulate clinically validated molecules into needle-free therapeutics for chronic diseases. Anodyne Nanotech is based in Boston, MA and was founded in 2019. Its last reported valuation was $7 million in Aug 2020. It has raised $9.6 million across 3 recorded rounds; the latest was a $12.6 million early-stage round in May 2026.
Last reported valuation
$7.0M
Oct 2026
Priced at
—
Total raised
$9.6M
Last round
Early Stage VC
May 2026
Team — not yet on record
No current team members for Anodyne Nanotech are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Anodyne Nanotech with a free account
·Watch Anodyne Nanotech: the Monday email on marks, rounds and moves
